ACERUS OTC Stock Technical Analysis

ASPCF -  USA Stock  

USD 0.03  0.0018  6.38%

As of the 17th of October 2021, ACERUS PHARMACEUTICALS shows the coefficient of variation of 6097.0, and Mean Deviation of 6.4. ACERUS PHARMACEUTICALS technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the entity's future prices. Put another way, you can use this information to find out if the entity will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to break down nineteen technical drivers for ACERUS PHARMACEUTICALS CORP, which can be compared to its rivals. Please confirm ACERUS PHARMACEUTICALS downside deviation, treynor ratio, expected short fall, as well as the relationship between the variance and potential upside to decide if ACERUS PHARMACEUTICALS is priced fairly, providing market reflects its regular price of 0.03 per share. As ACERUS PHARMACEUTICALS appears to be a penny stock we also recommend to validate its total risk alpha numbers.

ACERUS Technical Analysis 

 
Refresh
ACERUS PHARMACEUTICALS technical otc stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of ACERUS PHARMACEUTICALS technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of ACERUS PHARMACEUTICALS trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

ACERUS PHARMACEUTICALS Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was thirty with a total number of output elements of thirty-one. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of ACERUS PHARMACEUTICALS volatility. High ATR values indicate high volatility, and low values indicate low volatility. View also all equity analysis or get more info about average true range volatility indicators indicator.

ACERUS PHARMACEUTICALS Trend Analysis

Use this graph to draw trend lines for ACERUS PHARMACEUTICALS CORP. You can use it to identify possible trend reversals for ACERUS PHARMACEUTICALS as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual ACERUS PHARMACEUTICALS price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

ACERUS PHARMACEUTICALS Best Fit Change Line

The following chart estimates an ordinary least squares regression model for ACERUS PHARMACEUTICALS CORP applied against its price change over selected period. The best fit line has a slop of   -0.0001  , which may suggest that ACERUS PHARMACEUTICALS CORP market price will keep on failing further. It has 122 observation points and a regression sum of squares at 0.0, which is the sum of squared deviations for the predicted ACERUS PHARMACEUTICALS price change compared to its average price change.

About ACERUS PHARMACEUTICALS Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of ACERUS PHARMACEUTICALS CORP on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of ACERUS PHARMACEUTICALS CORP based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on ACERUS PHARMACEUTICALS stock first instead of the macroeconomic environment surrounding ACERUS PHARMACEUTICALS. By analyzing ACERUS PHARMACEUTICALS's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of ACERUS PHARMACEUTICALS's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to ACERUS PHARMACEUTICALS specific price patterns or momentum indicators. Please read more on our technical analysis page.

ACERUS PHARMACEUTICALS October 17, 2021 Technical Indicators

Most technical analysis of ACERUS help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for ACERUS from various momentum indicators to cycle indicators. When you analyze ACERUS charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

ACERUS PHARMACEUTICALS October 17, 2021 Daily Trend Indicators

Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as ACERUS stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
Please continue to Trending Equities. Note that the ACERUS PHARMACEUTICALS information on this page should be used as a complementary analysis to other ACERUS PHARMACEUTICALS's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Complementary Tools for ACERUS OTC Stock analysis

When running ACERUS PHARMACEUTICALS price analysis, check to measure ACERUS PHARMACEUTICALS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ACERUS PHARMACEUTICALS is operating at the current time. Most of ACERUS PHARMACEUTICALS's value examination focuses on studying past and present price action to predict the probability of ACERUS PHARMACEUTICALS's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move ACERUS PHARMACEUTICALS's price. Additionally, you may evaluate how the addition of ACERUS PHARMACEUTICALS to your portfolios can decrease your overall portfolio volatility.
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Go
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
The market value of ACERUS PHARMACEUTICALS is measured differently than its book value, which is the value of ACERUS that is recorded on the company's balance sheet. Investors also form their own opinion of ACERUS PHARMACEUTICALS's value that differs from its market value or its book value, called intrinsic value, which is ACERUS PHARMACEUTICALS's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ACERUS PHARMACEUTICALS's market value can be influenced by many factors that don't directly affect ACERUS PHARMACEUTICALS underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ACERUS PHARMACEUTICALS's value and its price as these two are different measures arrived at by different means. Investors typically determine ACERUS PHARMACEUTICALS value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ACERUS PHARMACEUTICALS's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.